|4Feb 26, 6:30 PM ET

ENDOCYTE INC 4

4 · ENDOCYTE INC · Filed Feb 26, 2015

Insider Transaction Report

Form 4
Period: 2015-02-06
Ellis P Ron
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2015-02-06$5.21/sh+52,356$272,775305,196 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-02-06+52,3560 total
    Exercise: $5.21Exp: 2017-05-31Common Stock (52,356 underlying)
Footnotes (1)
  • [F1]The option is fully vested and immediately exercisable.

Documents

1 file
  • 4
    v403027_4.xmlPrimary

    OWNERSHIP DOCUMENT